“A NOVEL ANTIBIOTIC TO TREAT BACTERIAL CONJUNCTIVITIS – BESIFLOXACIN”. International Journal of Pharmaceutical Drug Design, vol. 1, no. 1, Dec. 2023, https://doi.org/10.62896/269mps08.